Skip to Content

'
Anita K. Ying, M.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Executive Medical Director, Division of Ofc/EVP, Physician-in-Chief, The University of Texas MD Anderson Cancer Center, Houston, TX
Clinical Medical Director, Endocrine Center, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Associate Professor, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
Department of Endocrine Neoplasia and Hormonal Disorders
1515 Holcombe Blvd
Unit Number: 1461
Houston, TX 77030
Room Number: FCT 12.5018
Phone: 713-792-2841
Fax: 713-794-4065

Education & Training

Degree-Granting Education

1999 Duke University School of Medicine, Durham, NC, MD, Medicine
1994 Rice University, Houston, TX, BA, Cum Laude, Sociology

Postgraduate Training

7/2004-6/2008 Clinical Fellowship, Adult and Pediatric Endocrinology, Baylor College of Medicine and The University of Texas MD Anderson Cancer Center, Houston, TX, Ashok Balasubramanyam, M.D. and Morey Haymond, M.D.
7/2000-6/2003 Clinical Residency, Internal Medicine and Pediatrics, Duke University Medical Center, Durham, NC, Suzanne Woods, M.D.
7/1999-6/2000 Clinical Internship, Internal Medicine and Pediatrics, Duke University Medical Center, Durham, NC, Suzanne Woods, M.D.

Board Certifications

11/2009 Pediatric Endocrinology
11/2008 Endocrinology, Diabetes, and Metabolism

Experience/Service

Academic Appointments

Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2008-8/2015
Assistant Professor, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2008-8/2015
Co-Chief Resident and Associate in Pediatrics, Duke University Medical Center, Durham, NC, 2003-2004
Assistant Chief Resident in Internal Medicine, Duke University Medical Center, Durham, NC, 2002

Administrative Appointments/Responsibilities

Quality Officer, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2011-present

Other Appointments/Responsibilities

One Connect/EPIC SuperUser, UT MD Anderson Cancer Center, Houston, TX, 11/2015-present
Member, Jones Partners Board, Houston, TX, 9/2015-present
Member, San Jose Clinic, Board of Directors, Houston, TX, 12/2013-present
Chair, Program Services Board Committee, San Jose Clinic, Houston, TX, 12/2013-present
Member, Board of Directors, The Stanley J. Sarnoff Endowment for Cardiovascular Science, Great Falls, VA, 6/2010-5/2011
Housestaff Elected Representative, Duke University Medical Center, Executive Committee of Medical Staff, Houston, TX, 2001-2003

Institutional Committee Activities

Member, Real-time Locating System (RTLS) Strategic Initiative, 1/2015-present
Faculty Sponsor, Financial Clearance Center Steering Committee, 1/2015-present
Faculty Leader, Procedural Software Leadership Team, 5/2014-present
Faculty Leader, Time Driven Activity Based Costing Software Team, 5/2014-present
Member, One Connect/EPIC Intergrated Clinical Team, 4/2014-present
Faculty Associate, Institute for Cancer Care Innovation, 9/2013-present
Member, Faculty Recognition Plan Work Group, 9/2013-3/2014
Co-Chair, Strategic Assessment of Clinical Programs Steering Committee, 6/2011-3/2013
Member, Expense Analysis Clinical Operations Subcommittee, 2/2011-4/2011
Member, Physician Relations Advisory Board, 2011-present

Honors and Awards

2013 Jones Scholar Award, Rice University Jesse H. Jones Graduate School of Business
2012-present Beta Gamma Sigma Business Honor Society, Association to Advance Collegiate School of Business
1997 Four Schools Physician-Scientist Fellowship
1997 The Stanley J. Sarnoff Cardiovascular Scientific Science Fellowship

Professional Memberships

American College of Healthcare Executives, Chicago, IL
Member, 10/2014-present
American College of Medical Quality, Bethesda, MD
Member, 10/2008-present
American Society of Clinical Oncologists, Alexandria, VA
Member, 10/2013-present
American Thyroid Association, Falls Church, VA
Member, 5/2015-present
Harris County Medical Society, Houston, TX
Member, 3/2009-present
Pediatric Endocrine Society
Member, 11/2008-present
Texas Medical Association
Member, 3/2009-present
The Endocrine Society
Member, 6/2005-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Dadu R, Hu MI, Cleeland CS, Busaidy N, Habra MA, Waguespack SG, Sherman SI, Ying AK, Fox P, Cabanillas M. The efficacy of the natural clay, Calcium Aluminosilicate Anti-Diarrheal (CASAD), in reducing medullary thyroid cancer-related diarrhea and its effects on quality of life: a pilot study. Thyroid. e-Pub 7/22/2015. PMID: 26200040.
2. Lairmore TC, Diesen D, Goldfarb M, Milas M, Ying AK, Sharma J, McIver B, Wong RJ, Randolph G, AACE Endocrine Surgery Scientific Committee. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: TIMING OF MULTIPLE ENDOCRINE NEOPLASIA THYROIDECTOMY AND EXTENT OF CENTRAL NECK LYMPHADENECTOMY. Endocr Pract 21(7):839-47, 7/2015. PMID: 26172129.
3. Feng L, Busaidy N, Cote GJ, Gagel RF, Hu MI, Jimenez C, Lee JE, Perrier N, Sherman SI, Waguespack SG, Ying AK, Grubbs EG. Prevalence by Age and Predictors of Medullary Thyroid Cancer in Patients with Lower Risk Germline RET Proto-Oncogene Mutations. Thyroid 24(7):1096-106, 7/2014. PMCID: PMC4080849.
4. Dadu R, Devine C, Hernandez M, Waguespack SG, Busaidy NL, Hu MI, Jimenez C, Habra MA, Sellin RV, Ying AK, Cote GJ, Sherman SI, Cabanillas ME. Role of Salvage Targeted Therapy in Differentiated Thyroid Cancer Patients Who Failed First-Line Sorafenib. J Clin Endocrinol Metab 99(6):2086-94, 6/2014. e-Pub 3/14/2014. PMCID: PMC4037722.
5. Dadu R, Waguespack SG, Sherman SI, Hu MI, Busaidy NL, Jimenez C, Habra MA, Ying AK, Bassett RL, Cabanillas ME. Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients with Differentiated Thyroid Cancer. Oncologist 19(5):477-82, 5/2014. e-Pub 4/14/2014. PMCID: PMC4012968.
6. Carhill AA, Cabanillas ME, Jimenez C, Waguespack SG, Habra MA, Hu M, Ying A, Vassilopoulou-Sellin R, Gagel RF, Sherman SI, Busaidy NL. The Noninvestigational Use of Tyrosine Kinase Inhibitors in Thyroid Cancer: Establishing a Standard for Patient Safety and Monitoring. J Clin Endocrinol Metab 98(1):31-42, 1/2013. e-Pub 11/26/2012. PMCID: PMC3537108.
7. Morris LF, Waguespack SG, Edeiken-Monroe BS, Lee JE, Rich TA, Ying AK, Warneke CL, Evans DB, Perrier ND, Grubbs EG. Ultrasonography Should Not Guide the Timing of Thyroidectomy in Pediatric Patients Diagnosed with Multiple Endocrine Neoplasia Syndrome 2A through Genetic Screening. Ann Surg Oncol 20(1):53-9, 1/2013. e-Pub 8/14/2012. PMCID: PMC3892987.
8. Morris LF, Waguespack SG, Warneke CL, Ryu H, Ying AK, Anderson BJ, Sturgis EM, Clayman GL, Lee JE, Evans DB, Grubbs EG, Perrier ND. Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy. Surgery 152(6):1165-71, 12/2012. PMID: 23158186.
9. Ying AK, Lairson DR, Giardino AP, Bondy ML, Zaheer I, Haymond MW, Heptulla RA. Predictors of direct costs of diabetes care in pediatric patients with type 1 diabetes. Pediatr Diabetes 12(3 Pt 1):177-82, 5/2011. e-Pub 8/30/2010. PMID: 20807368.
10. Grubbs EG, Waguespack SG, Rich TA, Xing Y, Ying AK, Evans DB, Lee JE, Perrier ND. Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A? Surgery 148(6):1302-10, 12/2010. PMID: 21134565.
11. Jasim S, Ying AK, Waguespack SG, Rich TA, Grubbs EG, Jimenez C, Hu MI, Cote G, Habra MA. Multiple Endocrine Neoplasia Type 2B with a RET Proto-Oncogene A883F Mutation Displays a More Indolent Form of Medullary Thyroid Carcinoma Compared with a RET M918T Mutation. Thyroid 21(2), 2. e-Pub 12/2010.
12. Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 95(5):2023-37, 5/2010. e-Pub 3/9/2010. PMID: 20215394.
13. Ying AK, Hassanain HH, Roos CM, Smiraglia D, Issa JP. Methylation of the Estrogen Receptor-alpha Gene Promoter is Selectively Increased in proliferating human aortic smooth Muscle Cells. Cardiovascular Research 46:172-79, 2000.

Invited Articles

1. Ying AK, Feeley TW, Porter ME. Value-Based Healthcare - Implications for Thyroid Cancer. International Journal of Endocrine Oncology. In Press.
2. Dadu R, Shah K, Busaidy NL, Waguespack SG, Habra MA, Ying AK, Hu MI, Bassett R, Jimenez C, Sherman SI, Cabanillas ME. Efficacy and Tolerability of Vemurafenib in Patients with BRAFV600E -Positive Papillary Thyroid Cancer: M.D. Anderson Cancer Center Off Label Experience. J Clin Endocrinol Metab 100(1):E77-81, 1/2015. PMID: 25353071.
3. Hu MI, Ying AK, Jimenez C. Update on Medullary Thyroid Cancer. Endocrinol Metab Clin North Am 43(2):423–442, 6/2014. PMID: 24891170.
4. Ying AK, Huh W, Bottomley S, Evans D, Waguespack S.. Thyroid Cancer in Young Adults. Semin Oncol 36(3):258-74, 2009. PMID: 19460583.
Other Articles
1. Ying AK, Samson, SL. New Onset Hirsutism and Virilization in a Post-Menopausal Woman. MD Consult Grand Rounds in Endocrinology, 2007.

Book Chapters

1. Waguespack SG, Ying AK. Pheochromocytoma and Multiple Endocrine Neoplasia Syndromes. In: Pediatric Endocrinology, 4th. Ed(s) M Sperling, 2014.
2. Waguespack SG, Bauer AJ, Huh W, and Ying AK. Endocrine Tumors. In: Principles and Practice of Pediatric Endocrinology, 6th. Ed(s) Pizzo PA and Poplack DG. Lippincott Williams and Wilkins, 2010.

Last updated: 12/14/2015